

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | pyrimidine nucleobase catabolic process (GO:0006208) | 5.57926591 |
| 2 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.68229194 |
| 3 | nucleobase catabolic process (GO:0046113) | 4.42973206 |
| 4 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.24357142 |
| 5 | mitotic sister chromatid cohesion (GO:0007064) | 4.21140393 |
| 6 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.21016731 |
| 7 | negative regulation of cell killing (GO:0031342) | 4.21016731 |
| 8 | definitive hemopoiesis (GO:0060216) | 3.80328962 |
| 9 | positive regulation of mitochondrial membrane permeability involved in apoptotic process (GO:1902110 | 3.73862590 |
| 10 | mitochondrial outer membrane permeabilization involved in programmed cell death (GO:1902686) | 3.73862590 |
| 11 | epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287) | 3.73554341 |
| 12 | monoubiquitinated protein deubiquitination (GO:0035520) | 3.67216794 |
| 13 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.61862008 |
| 14 | pre-miRNA processing (GO:0031054) | 3.57235993 |
| 15 | nuclear pore complex assembly (GO:0051292) | 3.55607278 |
| 16 | regulation of histone H3-K9 methylation (GO:0051570) | 3.52291580 |
| 17 | cytoplasmic mRNA processing body assembly (GO:0033962) | 3.51472923 |
| 18 | central nervous system projection neuron axonogenesis (GO:0021952) | 3.41773003 |
| 19 | behavioral response to nicotine (GO:0035095) | 3.40797464 |
| 20 | regulation of gamma-delta T cell activation (GO:0046643) | 3.37012932 |
| 21 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.36600089 |
| 22 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.36600089 |
| 23 | negative T cell selection (GO:0043383) | 3.32994858 |
| 24 | negative regulation of histone methylation (GO:0031061) | 3.32320602 |
| 25 | presynaptic membrane assembly (GO:0097105) | 3.31429616 |
| 26 | presynaptic membrane organization (GO:0097090) | 3.30743521 |
| 27 | behavioral response to ethanol (GO:0048149) | 3.25285414 |
| 28 | negative thymic T cell selection (GO:0045060) | 3.24302708 |
| 29 | activated T cell proliferation (GO:0050798) | 3.22989210 |
| 30 | positive regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060213) | 3.11648979 |
| 31 | regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060211) | 3.11648979 |
| 32 | centriole replication (GO:0007099) | 3.07647754 |
| 33 | positive regulation of histone deacetylation (GO:0031065) | 3.03532669 |
| 34 | resolution of meiotic recombination intermediates (GO:0000712) | 3.03154595 |
| 35 | regulation of RNA export from nucleus (GO:0046831) | 3.03127359 |
| 36 | regulation of DNA endoreduplication (GO:0032875) | 3.02455350 |
| 37 | somite development (GO:0061053) | 3.01973478 |
| 38 | positive thymic T cell selection (GO:0045059) | 3.01668862 |
| 39 | nuclear pore organization (GO:0006999) | 3.01173862 |
| 40 | protein K11-linked deubiquitination (GO:0035871) | 3.01147018 |
| 41 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.98141534 |
| 42 | dendritic spine morphogenesis (GO:0060997) | 2.97469947 |
| 43 | DNA unwinding involved in DNA replication (GO:0006268) | 2.93237462 |
| 44 | T cell homeostasis (GO:0043029) | 2.93143420 |
| 45 | nonmotile primary cilium assembly (GO:0035058) | 2.91268439 |
| 46 | megakaryocyte development (GO:0035855) | 2.89304428 |
| 47 | transmission of nerve impulse (GO:0019226) | 2.88464829 |
| 48 | negative regulation of translation involved in gene silencing by miRNA (GO:0035278) | 2.87897580 |
| 49 | negative regulation of translation, ncRNA-mediated (GO:0040033) | 2.87897580 |
| 50 | regulation of translation, ncRNA-mediated (GO:0045974) | 2.87897580 |
| 51 | mRNA splice site selection (GO:0006376) | 2.87818416 |
| 52 | RNA stabilization (GO:0043489) | 2.83617266 |
| 53 | mRNA stabilization (GO:0048255) | 2.83617266 |
| 54 | forebrain neuron differentiation (GO:0021879) | 2.83404672 |
| 55 | positive T cell selection (GO:0043368) | 2.83368712 |
| 56 | limb bud formation (GO:0060174) | 2.83161764 |
| 57 | protein-DNA complex disassembly (GO:0032986) | 2.82753166 |
| 58 | nucleosome disassembly (GO:0006337) | 2.82753166 |
| 59 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 2.81383898 |
| 60 | positive regulation of erythrocyte differentiation (GO:0045648) | 2.81087294 |
| 61 | thymic T cell selection (GO:0045061) | 2.80985380 |
| 62 | central nervous system neuron axonogenesis (GO:0021955) | 2.79765539 |
| 63 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 2.79155644 |
| 64 | histone H3-K4 trimethylation (GO:0080182) | 2.78427543 |
| 65 | intraciliary transport (GO:0042073) | 2.77810344 |
| 66 | glial cell proliferation (GO:0014009) | 2.77728334 |
| 67 | nerve growth factor signaling pathway (GO:0038180) | 2.76524599 |
| 68 | neuron cell-cell adhesion (GO:0007158) | 2.76271844 |
| 69 | T cell selection (GO:0045058) | 2.73756432 |
| 70 | positive regulation of developmental pigmentation (GO:0048087) | 2.73335196 |
| 71 | positive regulation of mitochondrial fission (GO:0090141) | 2.73202208 |
| 72 | DNA topological change (GO:0006265) | 2.72597505 |
| 73 | embryonic hemopoiesis (GO:0035162) | 2.69341218 |
| 74 | regulation of erythrocyte differentiation (GO:0045646) | 2.69054225 |
| 75 | epithelial cell differentiation involved in kidney development (GO:0035850) | 2.68816032 |
| 76 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.68636770 |
| 77 | positive regulation of B cell differentiation (GO:0045579) | 2.67253950 |
| 78 | histone mRNA catabolic process (GO:0071044) | 2.66871128 |
| 79 | establishment of protein localization to Golgi (GO:0072600) | 2.65567184 |
| 80 | ribosomal small subunit assembly (GO:0000028) | 2.64696477 |
| 81 | pore complex assembly (GO:0046931) | 2.64137889 |
| 82 | synapse assembly (GO:0007416) | 2.63271873 |
| 83 | positive regulation of granulocyte differentiation (GO:0030854) | 2.62310051 |
| 84 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 2.62271975 |
| 85 | alternative mRNA splicing, via spliceosome (GO:0000380) | 2.62202535 |
| 86 | B cell homeostasis (GO:0001782) | 2.62114609 |
| 87 | negative regulation of RNA splicing (GO:0033119) | 2.61498409 |
| 88 | dentate gyrus development (GO:0021542) | 2.61317429 |
| 89 | protein targeting to Golgi (GO:0000042) | 2.61042264 |
| 90 | peptidyl-lysine trimethylation (GO:0018023) | 2.58234475 |
| 91 | glucocorticoid receptor signaling pathway (GO:0042921) | 2.57911751 |
| 92 | positive regulation of mRNA processing (GO:0050685) | 2.57184520 |
| 93 | phosphatidylinositol-3-phosphate biosynthetic process (GO:0036092) | 2.57054232 |
| 94 | regulation of telomere maintenance (GO:0032204) | 2.56527527 |
| 95 | positive regulation of mRNA catabolic process (GO:0061014) | 2.56503656 |
| 96 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.56306355 |
| 97 | embryonic epithelial tube formation (GO:0001838) | 2.55221149 |
| 98 | regulation of nucleobase-containing compound transport (GO:0032239) | 2.53853092 |
| 99 | mast cell activation (GO:0045576) | 2.53816455 |
| 100 | chromatin assembly (GO:0031497) | 2.53574611 |
| 101 | positive regulation of phosphoprotein phosphatase activity (GO:0032516) | 2.53466150 |
| 102 | histone H3-K9 methylation (GO:0051567) | 2.53002846 |
| 103 | lymphocyte homeostasis (GO:0002260) | 2.52929054 |
| 104 | germ cell migration (GO:0008354) | 2.52887650 |
| 105 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.52806209 |
| 106 | sequestering of actin monomers (GO:0042989) | 2.52561180 |
| 107 | histone H3-K9 demethylation (GO:0033169) | 2.52519553 |
| 108 | fucose catabolic process (GO:0019317) | 2.52255371 |
| 109 | L-fucose metabolic process (GO:0042354) | 2.52255371 |
| 110 | L-fucose catabolic process (GO:0042355) | 2.52255371 |
| 111 | positive regulation of mRNA metabolic process (GO:1903313) | 2.52027160 |
| 112 | B cell receptor signaling pathway (GO:0050853) | 2.51954141 |
| 113 | kidney morphogenesis (GO:0060993) | 2.51789784 |
| 114 | response to interleukin-15 (GO:0070672) | 2.51725564 |
| 115 | establishment of mitochondrion localization (GO:0051654) | 2.51702048 |
| 116 | interferon-gamma production (GO:0032609) | 2.51442524 |
| 117 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.50207585 |
| 118 | negative regulation of DNA repair (GO:0045738) | 2.50016007 |
| 119 | positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO | 2.49916940 |
| 120 | regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900151) | 2.49916940 |
| 121 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 2.48239199 |
| 122 | histone H3-K4 methylation (GO:0051568) | 2.47567980 |
| 123 | negative regulation of B cell proliferation (GO:0030889) | 2.46738683 |
| 124 | positive regulation of growth hormone secretion (GO:0060124) | 2.46620362 |
| 125 | DNA demethylation (GO:0080111) | 2.46295186 |
| 126 | regulation of regulatory T cell differentiation (GO:0045589) | 2.46186440 |
| 127 | retrograde transport, vesicle recycling within Golgi (GO:0000301) | 2.45853240 |
| 128 | regulation of B cell differentiation (GO:0045577) | 2.45414277 |
| 129 | neuron fate determination (GO:0048664) | 2.44844769 |
| 130 | regulation of mRNA stability (GO:0043488) | 2.44175099 |
| 131 | histone deubiquitination (GO:0016578) | 2.43768531 |
| 132 | cerebellar Purkinje cell differentiation (GO:0021702) | 2.43340570 |
| 133 | gamma-aminobutyric acid transport (GO:0015812) | 2.43302362 |
| 134 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.42979826 |
| 135 | startle response (GO:0001964) | 2.41473251 |
| 136 | neuronal action potential (GO:0019228) | 2.40738340 |
| 137 | protein localization to cilium (GO:0061512) | 2.40676974 |
| 138 | peptidyl-lysine methylation (GO:0018022) | 2.40455453 |
| 139 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 2.40284701 |
| 140 | epithelial cilium movement (GO:0003351) | 2.38497620 |
| 141 | regulation of mRNA catabolic process (GO:0061013) | 2.37813708 |
| 142 | pyrimidine dimer repair (GO:0006290) | 2.37431370 |
| 143 | translesion synthesis (GO:0019985) | 2.36838314 |
| 144 | negative regulation of phagocytosis (GO:0050765) | 2.36737555 |
| 145 | viral transcription (GO:0019083) | 2.36594101 |
| 146 | positive regulation of mRNA 3-end processing (GO:0031442) | 2.36048239 |
| 147 | T cell migration (GO:0072678) | 2.35919691 |
| 148 | axonal fasciculation (GO:0007413) | 2.35661781 |
| 149 | lymphoid progenitor cell differentiation (GO:0002320) | 2.35643306 |
| 150 | peptidyl-lysine dimethylation (GO:0018027) | 2.34776240 |
| 151 | negative regulation of mast cell activation (GO:0033004) | 2.34394526 |
| 152 | olfactory bulb development (GO:0021772) | 2.33731914 |
| 153 | corticosteroid receptor signaling pathway (GO:0031958) | 2.33704108 |
| 154 | regulation of RNA stability (GO:0043487) | 2.33069689 |
| 155 | epithelial tube formation (GO:0072175) | 2.32617100 |
| 156 | positive regulation of protein deacetylation (GO:0090312) | 2.32411529 |
| 157 | dosage compensation (GO:0007549) | 2.31750266 |
| 158 | postsynaptic membrane organization (GO:0001941) | 2.31389691 |
| 159 | cellular response to interleukin-15 (GO:0071350) | 2.30799996 |
| 160 | translational termination (GO:0006415) | 2.30727736 |
| 161 | interkinetic nuclear migration (GO:0022027) | 2.30578782 |
| 162 | peptidyl-threonine dephosphorylation (GO:0035970) | 2.30572625 |
| 163 | histone H3-K9 modification (GO:0061647) | 2.30558538 |
| 164 | T cell differentiation (GO:0030217) | 2.30372641 |
| 165 | acrosome assembly (GO:0001675) | 2.29776730 |
| 166 | regulation of collateral sprouting (GO:0048670) | 2.29577635 |
| 167 | auditory behavior (GO:0031223) | 2.28704295 |
| 168 | neuron recognition (GO:0008038) | 2.28254446 |
| 169 | mechanosensory behavior (GO:0007638) | 2.28117540 |
| 170 | sister chromatid cohesion (GO:0007062) | 2.27517601 |
| 171 | negative regulation of histone modification (GO:0031057) | 2.27326136 |
| 172 | DNA double-strand break processing (GO:0000729) | 2.27265316 |
| 173 | histone lysine methylation (GO:0034968) | 2.27141536 |
| 174 | RNA destabilization (GO:0050779) | 2.26744169 |
| 175 | negative regulation of neurotransmitter transport (GO:0051589) | 2.26546018 |
| 176 | microtubule depolymerization (GO:0007019) | 2.26099224 |
| 177 | regulation of pigment cell differentiation (GO:0050932) | 2.26098695 |
| 178 | glutamate receptor signaling pathway (GO:0007215) | 2.26075316 |
| 179 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 2.25377915 |
| 180 | neural tube formation (GO:0001841) | 2.24141013 |
| 181 | regulation of histone methylation (GO:0031060) | 2.22222598 |
| 182 | negative regulation of T cell mediated immunity (GO:0002710) | 2.22181041 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 5.96861445 |
| 2 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 5.16043353 |
| 3 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 4.17050766 |
| 4 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 4.13998326 |
| 5 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.95647388 |
| 6 | EZH2_22144423_ChIP-Seq_EOC_Human | 3.79361124 |
| 7 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 3.76473758 |
| 8 | IGF1R_20145208_ChIP-Seq_DFB_Human | 3.67817426 |
| 9 | MYC_22102868_ChIP-Seq_BL_Human | 3.64885030 |
| 10 | SCL_19346495_ChIP-Seq_HPC-7_Human | 3.23601035 |
| 11 | ZNF274_21170338_ChIP-Seq_K562_Hela | 3.19333279 |
| 12 | * POU3F2_20337985_ChIP-ChIP_501MEL_Human | 3.08963939 |
| 13 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.99589003 |
| 14 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.76852015 |
| 15 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.72400062 |
| 16 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.72260421 |
| 17 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 2.70504604 |
| 18 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.69084889 |
| 19 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 2.60265784 |
| 20 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.56739014 |
| 21 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.49638397 |
| 22 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.49199453 |
| 23 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.47295849 |
| 24 | FUS_26573619_Chip-Seq_HEK293_Human | 2.41047570 |
| 25 | VDR_22108803_ChIP-Seq_LS180_Human | 2.40477681 |
| 26 | * MYB_26560356_Chip-Seq_TH2_Human | 2.39155775 |
| 27 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.38683004 |
| 28 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.38636925 |
| 29 | EWS_26573619_Chip-Seq_HEK293_Human | 2.36982414 |
| 30 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.35550942 |
| 31 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.29736200 |
| 32 | * ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 2.23575098 |
| 33 | * MYB_26560356_Chip-Seq_TH1_Human | 2.13862273 |
| 34 | MAF_26560356_Chip-Seq_TH1_Human | 2.13432065 |
| 35 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 2.06528130 |
| 36 | UTX_26944678_Chip-Seq_JUKART_Human | 2.04487686 |
| 37 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 2.00604067 |
| 38 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.99768276 |
| 39 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.97533171 |
| 40 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.95259779 |
| 41 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.93952190 |
| 42 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.93028367 |
| 43 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.92996640 |
| 44 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.92490594 |
| 45 | * P300_19829295_ChIP-Seq_ESCs_Human | 1.89279433 |
| 46 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.86369070 |
| 47 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.84493968 |
| 48 | * ER_23166858_ChIP-Seq_MCF-7_Human | 1.82757980 |
| 49 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.78260425 |
| 50 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.76495424 |
| 51 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.74785269 |
| 52 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.74499690 |
| 53 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.73196600 |
| 54 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.73152404 |
| 55 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.72792719 |
| 56 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.71857353 |
| 57 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.70150521 |
| 58 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.69819941 |
| 59 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.69658827 |
| 60 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.68729795 |
| 61 | * KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 1.66958723 |
| 62 | GATA1_22025678_ChIP-Seq_K562_Human | 1.66910933 |
| 63 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.65889497 |
| 64 | * KDM2B_26808549_Chip-Seq_DND41_Human | 1.63861799 |
| 65 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.63033179 |
| 66 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.62365475 |
| 67 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.61494531 |
| 68 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.61494531 |
| 69 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.61270486 |
| 70 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 1.61084279 |
| 71 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.60853546 |
| 72 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.56669432 |
| 73 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.55716412 |
| 74 | * HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.54238300 |
| 75 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.53648215 |
| 76 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.51572073 |
| 77 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.50506672 |
| 78 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.50066491 |
| 79 | * SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.49506037 |
| 80 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.49199601 |
| 81 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.48964594 |
| 82 | PKCTHETA_26484144_Chip-Seq_BREAST_Human | 1.46902688 |
| 83 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.46384311 |
| 84 | * SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.46021285 |
| 85 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.45527465 |
| 86 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.44940759 |
| 87 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.44350291 |
| 88 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.44350291 |
| 89 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.41206972 |
| 90 | STAT3_23295773_ChIP-Seq_U87_Human | 1.40693660 |
| 91 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.37029221 |
| 92 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.36654346 |
| 93 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.36300623 |
| 94 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.35336035 |
| 95 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.34603762 |
| 96 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.34196207 |
| 97 | TCF4_23295773_ChIP-Seq_U87_Human | 1.33166522 |
| 98 | * HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.32593745 |
| 99 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.32533732 |
| 100 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.30333510 |
| 101 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.28759212 |
| 102 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.28197118 |
| 103 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.27810247 |
| 104 | * MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.27702958 |
| 105 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.27688880 |
| 106 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.26239676 |
| 107 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.25514202 |
| 108 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.25318252 |
| 109 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.24579915 |
| 110 | * VDR_23849224_ChIP-Seq_CD4+_Human | 1.24359286 |
| 111 | * CREM_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.23605827 |
| 112 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 1.22777254 |
| 113 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.22597282 |
| 114 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.21849431 |
| 115 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.21478838 |
| 116 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.20723119 |
| 117 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.19445341 |
| 118 | * SPI1_23127762_ChIP-Seq_K562_Human | 1.19324926 |
| 119 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.17328196 |
| 120 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.17088080 |
| 121 | AR_25329375_ChIP-Seq_VCAP_Human | 1.16753280 |
| 122 | * HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.16233772 |
| 123 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.16200353 |
| 124 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.15680634 |
| 125 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.14932129 |
| 126 | ETS1_22383799_ChIP-Seq_G1ME_Mouse | 1.14870575 |
| 127 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.14130880 |
| 128 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 1.13985611 |
| 129 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.13117786 |
| 130 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.11972084 |
| 131 | * ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.11900435 |
| 132 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.11574210 |
| 133 | * GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.11249277 |
| 134 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.10200528 |
| 135 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.08798612 |
| 136 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.06868958 |
| 137 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.06494685 |
| 138 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 1.05422043 |
| 139 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.05221122 |
| 140 | * CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.05200462 |
| 141 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.05074130 |
| 142 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 1.03996505 |
| 143 | * MAF_26560356_Chip-Seq_TH2_Human | 1.03501140 |
| 144 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.03498020 |
| 145 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.03392942 |
| 146 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.01770012 |
| 147 | TAL1_21186366_ChIP-Seq_BM-HSCs_Mouse | 1.01507411 |
| 148 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 0.99289457 |
| 149 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 0.98175953 |
| 150 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 0.97742600 |
| 151 | MYC_18940864_ChIP-ChIP_HL60_Human | 0.97352362 |
| 152 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 0.97190358 |
| 153 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 0.96628446 |
| 154 | TCF4_22108803_ChIP-Seq_LS180_Human | 0.95442889 |
| 155 | * FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.95242591 |
| 156 | CEBPB_26923725_Chip-Seq_MESODERM_Mouse | 0.93442931 |
| 157 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 0.93089108 |
| 158 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 0.92637732 |
| 159 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 0.92224678 |
| 160 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 0.92166180 |
| 161 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 0.91574652 |
| 162 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.91454088 |
| 163 | * FOXM1_26100407_CHIP-SEQ_Hek293_flp-in_Human | 0.90178225 |
| 164 | HOXD13_18407260_ChIP-ChIP_DEVELOPING-LIMBS_Mouse | 0.89478010 |
| 165 | * NCOR1_26117541_ChIP-Seq_K562_Human | 0.89299392 |
| 166 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.87973553 |
| 167 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.87123828 |
| 168 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 0.86121853 |
| 169 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.85595588 |
| 170 | ELK1_19687146_ChIP-ChIP_HELA_Human | 0.81252543 |
| 171 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 0.80848051 |
| 172 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.80667319 |
| 173 | KDM5A_27292631_Chip-Seq_BREAST_Human | 0.80373986 |
| 174 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 0.80018436 |
| 175 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.79529527 |
| 176 | GATA1_19941826_ChIP-Seq_K562_Human | 0.79290401 |
| 177 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.78492096 |
| 178 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 0.77289881 |
| 179 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 0.76213789 |
| 180 | GATA3_26560356_Chip-Seq_TH2_Human | 0.75039802 |
| 181 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.75023038 |
| 182 | * CHD1_26751641_Chip-Seq_LNCaP_Human | 0.73920803 |
| 183 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.73539819 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003880_abnormal_central_pattern | 3.30794952 |
| 2 | MP0003303_peritoneal_inflammation | 3.25299661 |
| 3 | MP0004808_abnormal_hematopoietic_stem | 2.91955769 |
| 4 | MP0000569_abnormal_digit_pigmentation | 2.83808061 |
| 5 | MP0003763_abnormal_thymus_physiology | 2.77008091 |
| 6 | MP0002166_altered_tumor_susceptibility | 2.55108043 |
| 7 | MP0005671_abnormal_response_to | 2.50009180 |
| 8 | MP0002396_abnormal_hematopoietic_system | 2.49356440 |
| 9 | MP0005174_abnormal_tail_pigmentation | 2.39973309 |
| 10 | MP0005076_abnormal_cell_differentiation | 2.32195915 |
| 11 | MP0002398_abnormal_bone_marrow | 2.26530382 |
| 12 | MP0005645_abnormal_hypothalamus_physiol | 2.23389354 |
| 13 | MP0000778_abnormal_nervous_system | 2.22157853 |
| 14 | MP0003300_gastrointestinal_ulcer | 2.18344227 |
| 15 | MP0001800_abnormal_humoral_immune | 2.10319374 |
| 16 | MP0001529_abnormal_vocalization | 2.10095417 |
| 17 | MP0008057_abnormal_DNA_replication | 2.09244888 |
| 18 | MP0002009_preneoplasia | 2.06031808 |
| 19 | MP0006054_spinal_hemorrhage | 2.04994462 |
| 20 | MP0000703_abnormal_thymus_morphology | 2.00817715 |
| 21 | MP0005423_abnormal_somatic_nervous | 1.95311707 |
| 22 | MP0001835_abnormal_antigen_presentation | 1.94829617 |
| 23 | MP0002006_tumorigenesis | 1.90377993 |
| 24 | MP0010352_gastrointestinal_tract_polyps | 1.85971014 |
| 25 | MP0010094_abnormal_chromosome_stability | 1.85221043 |
| 26 | MP0002420_abnormal_adaptive_immunity | 1.84587563 |
| 27 | MP0003787_abnormal_imprinting | 1.83278354 |
| 28 | MP0001819_abnormal_immune_cell | 1.81404443 |
| 29 | MP0002638_abnormal_pupillary_reflex | 1.78686884 |
| 30 | MP0002452_abnormal_antigen_presenting | 1.76676045 |
| 31 | MP0000716_abnormal_immune_system | 1.76269825 |
| 32 | MP0003122_maternal_imprinting | 1.76088619 |
| 33 | MP0004142_abnormal_muscle_tone | 1.75847629 |
| 34 | MP0005000_abnormal_immune_tolerance | 1.75405662 |
| 35 | MP0002722_abnormal_immune_system | 1.72435831 |
| 36 | MP0005397_hematopoietic_system_phenotyp | 1.71908399 |
| 37 | MP0001545_abnormal_hematopoietic_system | 1.71908399 |
| 38 | MP0006276_abnormal_autonomic_nervous | 1.70714219 |
| 39 | MP0002723_abnormal_immune_serum | 1.70418025 |
| 40 | MP0003436_decreased_susceptibility_to | 1.69164606 |
| 41 | MP0000685_abnormal_immune_system | 1.66633077 |
| 42 | MP0005387_immune_system_phenotype | 1.65038747 |
| 43 | MP0001790_abnormal_immune_system | 1.65038747 |
| 44 | MP0000689_abnormal_spleen_morphology | 1.62894501 |
| 45 | MP0002822_catalepsy | 1.61714932 |
| 46 | MP0001968_abnormal_touch/_nociception | 1.60807751 |
| 47 | MP0003635_abnormal_synaptic_transmissio | 1.60122165 |
| 48 | MP0000631_abnormal_neuroendocrine_gland | 1.59445077 |
| 49 | MP0002095_abnormal_skin_pigmentation | 1.58450186 |
| 50 | MP0001188_hyperpigmentation | 1.56656522 |
| 51 | MP0001984_abnormal_olfaction | 1.55622366 |
| 52 | MP0003077_abnormal_cell_cycle | 1.55300332 |
| 53 | MP0002405_respiratory_system_inflammati | 1.55000997 |
| 54 | MP0005464_abnormal_platelet_physiology | 1.54281210 |
| 55 | MP0002877_abnormal_melanocyte_morpholog | 1.52845987 |
| 56 | MP0002429_abnormal_blood_cell | 1.52552256 |
| 57 | MP0001486_abnormal_startle_reflex | 1.51521007 |
| 58 | MP0004742_abnormal_vestibular_system | 1.51429283 |
| 59 | MP0010155_abnormal_intestine_physiology | 1.51348766 |
| 60 | MP0005646_abnormal_pituitary_gland | 1.51018143 |
| 61 | MP0009745_abnormal_behavioral_response | 1.49779120 |
| 62 | MP0010234_abnormal_vibrissa_follicle | 1.47957241 |
| 63 | MP0000015_abnormal_ear_pigmentation | 1.46027431 |
| 64 | MP0003111_abnormal_nucleus_morphology | 1.44256254 |
| 65 | MP0000490_abnormal_crypts_of | 1.43557689 |
| 66 | MP0009785_altered_susceptibility_to | 1.43551915 |
| 67 | MP0006072_abnormal_retinal_apoptosis | 1.43319759 |
| 68 | MP0008995_early_reproductive_senescence | 1.43263356 |
| 69 | MP0005025_abnormal_response_to | 1.42734569 |
| 70 | MP0005084_abnormal_gallbladder_morpholo | 1.41131959 |
| 71 | MP0009046_muscle_twitch | 1.40338884 |
| 72 | MP0002063_abnormal_learning/memory/cond | 1.40259473 |
| 73 | MP0009278_abnormal_bone_marrow | 1.38838839 |
| 74 | MP0000465_gastrointestinal_hemorrhage | 1.38779268 |
| 75 | MP0002735_abnormal_chemical_nociception | 1.37317127 |
| 76 | MP0010307_abnormal_tumor_latency | 1.36380246 |
| 77 | MP0005394_taste/olfaction_phenotype | 1.36174082 |
| 78 | MP0005499_abnormal_olfactory_system | 1.36174082 |
| 79 | MP0002272_abnormal_nervous_system | 1.32619992 |
| 80 | MP0002277_abnormal_respiratory_mucosa | 1.31982193 |
| 81 | MP0003866_abnormal_defecation | 1.31130741 |
| 82 | MP0005253_abnormal_eye_physiology | 1.30711631 |
| 83 | MP0002572_abnormal_emotion/affect_behav | 1.30473527 |
| 84 | MP0002184_abnormal_innervation | 1.30275263 |
| 85 | MP0004270_analgesia | 1.27389459 |
| 86 | MP0004924_abnormal_behavior | 1.26913121 |
| 87 | MP0005386_behavior/neurological_phenoty | 1.26913121 |
| 88 | MP0002751_abnormal_autonomic_nervous | 1.26188872 |
| 89 | MP0002067_abnormal_sensory_capabilities | 1.25091394 |
| 90 | MP0005410_abnormal_fertilization | 1.24412366 |
| 91 | MP0009333_abnormal_splenocyte_physiolog | 1.23481303 |
| 92 | MP0002736_abnormal_nociception_after | 1.22543909 |
| 93 | MP0008877_abnormal_DNA_methylation | 1.21967761 |
| 94 | MP0008789_abnormal_olfactory_epithelium | 1.21802202 |
| 95 | MP0000537_abnormal_urethra_morphology | 1.21602069 |
| 96 | MP0002419_abnormal_innate_immunity | 1.21178605 |
| 97 | MP0002064_seizures | 1.20429339 |
| 98 | MP0005075_abnormal_melanosome_morpholog | 1.20343080 |
| 99 | MP0002557_abnormal_social/conspecific_i | 1.19986204 |
| 100 | MP0008007_abnormal_cellular_replicative | 1.17412272 |
| 101 | MP0000350_abnormal_cell_proliferation | 1.16449127 |
| 102 | MP0005367_renal/urinary_system_phenotyp | 1.15790615 |
| 103 | MP0000516_abnormal_urinary_system | 1.15790615 |
| 104 | MP0003943_abnormal_hepatobiliary_system | 1.13272985 |
| 105 | MP0002102_abnormal_ear_morphology | 1.13117598 |
| 106 | MP0004885_abnormal_endolymph | 1.12861054 |
| 107 | MP0003221_abnormal_cardiomyocyte_apopto | 1.12136427 |
| 108 | MP0001293_anophthalmia | 1.10526351 |
| 109 | MP0005551_abnormal_eye_electrophysiolog | 1.09549299 |
| 110 | MP0002019_abnormal_tumor_incidence | 1.07986947 |
| 111 | MP0008058_abnormal_DNA_repair | 1.07223376 |
| 112 | MP0002148_abnormal_hypersensitivity_rea | 1.07097780 |
| 113 | MP0004811_abnormal_neuron_physiology | 1.05272500 |
| 114 | MP0000955_abnormal_spinal_cord | 1.04776232 |
| 115 | MP0004947_skin_inflammation | 1.03824635 |
| 116 | MP0002928_abnormal_bile_duct | 1.02117736 |
| 117 | MP0003121_genomic_imprinting | 1.01706219 |
| 118 | MP0001851_eye_inflammation | 1.01080505 |
| 119 | MP0002909_abnormal_adrenal_gland | 1.00217975 |
| 120 | MP0001873_stomach_inflammation | 1.00093635 |
| 121 | MP0002882_abnormal_neuron_morphology | 0.99432934 |
| 122 | MP0000372_irregular_coat_pigmentation | 0.98536891 |
| 123 | MP0002734_abnormal_mechanical_nocicepti | 0.98334156 |
| 124 | MP0001845_abnormal_inflammatory_respons | 0.98029933 |
| 125 | MP0004133_heterotaxia | 0.96925290 |
| 126 | MP0004147_increased_porphyrin_level | 0.95693735 |
| 127 | MP0004859_abnormal_synaptic_plasticity | 0.92085233 |
| 128 | MP0002152_abnormal_brain_morphology | 0.91917000 |
| 129 | MP0000371_diluted_coat_color | 0.89299418 |
| 130 | MP0003890_abnormal_embryonic-extraembry | 0.89255944 |
| 131 | MP0004145_abnormal_muscle_electrophysio | 0.88202518 |
| 132 | MP0002752_abnormal_somatic_nervous | 0.87295803 |
| 133 | MP0001970_abnormal_pain_threshold | 0.86871240 |
| 134 | MP0002086_abnormal_extraembryonic_tissu | 0.85888086 |
| 135 | MP0000313_abnormal_cell_death | 0.83030322 |
| 136 | MP0003567_abnormal_fetal_cardiomyocyte | 0.81575213 |
| 137 | MP0008961_abnormal_basal_metabolism | 0.81504432 |
| 138 | MP0003172_abnormal_lysosome_physiology | 0.81414407 |
| 139 | MP0002075_abnormal_coat/hair_pigmentati | 0.80708236 |
| 140 | MP0003698_abnormal_male_reproductive | 0.80330973 |
| 141 | MP0002084_abnormal_developmental_patter | 0.80166219 |
| 142 | MP0003938_abnormal_ear_development | 0.80154401 |
| 143 | MP0000383_abnormal_hair_follicle | 0.79551027 |
| 144 | MP0004197_abnormal_fetal_growth/weight/ | 0.79438568 |
| 145 | MP0006292_abnormal_olfactory_placode | 0.79185168 |
| 146 | MP0001348_abnormal_lacrimal_gland | 0.78661263 |
| 147 | MP0000858_altered_metastatic_potential | 0.78069830 |
| 148 | MP0008872_abnormal_physiological_respon | 0.77515250 |
| 149 | MP0002160_abnormal_reproductive_system | 0.77497418 |
| 150 | MP0002733_abnormal_thermal_nociception | 0.75777492 |
| 151 | MP0003861_abnormal_nervous_system | 0.75359708 |
| 152 | MP0000427_abnormal_hair_cycle | 0.74540431 |
| 153 | MP0002210_abnormal_sex_determination | 0.74438596 |
| 154 | MP0001697_abnormal_embryo_size | 0.74426759 |
| 155 | MP0002925_abnormal_cardiovascular_devel | 0.74203809 |
| 156 | MP0003448_altered_tumor_morphology | 0.73987584 |
| 157 | MP0001502_abnormal_circadian_rhythm | 0.73923015 |
| 158 | MP0001915_intracranial_hemorrhage | 0.72841252 |
| 159 | MP0009703_decreased_birth_body | 0.72475472 |
| 160 | MP0001929_abnormal_gametogenesis | 0.72301975 |
| 161 | MP0005409_darkened_coat_color | 0.72012413 |
| 162 | MP0008770_decreased_survivor_rate | 0.71842396 |
| 163 | MP0002088_abnormal_embryonic_growth/wei | 0.71485319 |
| 164 | MP0001905_abnormal_dopamine_level | 0.71482778 |
| 165 | MP0003045_fibrosis | 0.71338732 |
| 166 | MP0005187_abnormal_penis_morphology | 0.71327546 |
| 167 | MP0003984_embryonic_growth_retardation | 0.70109777 |
| 168 | MP0000647_abnormal_sebaceous_gland | 0.69371029 |
| 169 | MP0005391_vision/eye_phenotype | 0.68984450 |
| 170 | MP0003693_abnormal_embryo_hatching | 0.68475127 |
| 171 | MP0004484_altered_response_of | 0.68421626 |
| 172 | MP0000733_abnormal_muscle_development | 0.68067358 |
| 173 | MP0002092_abnormal_eye_morphology | 0.67866682 |
| 174 | MP0001986_abnormal_taste_sensitivity | 0.67599539 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of the fingertips (HP:0001211) | 4.27710410 |
| 2 | Volvulus (HP:0002580) | 3.83837486 |
| 3 | Hyperventilation (HP:0002883) | 3.70147553 |
| 4 | Thrombocytosis (HP:0001894) | 3.58565537 |
| 5 | Type II lissencephaly (HP:0007260) | 3.27685944 |
| 6 | Medial flaring of the eyebrow (HP:0010747) | 3.16284822 |
| 7 | Retinal dysplasia (HP:0007973) | 3.07801150 |
| 8 | Gait imbalance (HP:0002141) | 3.07130949 |
| 9 | B lymphocytopenia (HP:0010976) | 2.95403001 |
| 10 | Abnormality of B cell number (HP:0010975) | 2.95403001 |
| 11 | Recurrent viral infections (HP:0004429) | 2.93926065 |
| 12 | Pancreatic cysts (HP:0001737) | 2.90004140 |
| 13 | Congenital primary aphakia (HP:0007707) | 2.86559270 |
| 14 | Febrile seizures (HP:0002373) | 2.83204449 |
| 15 | Drooling (HP:0002307) | 2.83118707 |
| 16 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 2.80889234 |
| 17 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 2.80889234 |
| 18 | Nasal polyposis (HP:0100582) | 2.80715705 |
| 19 | Myositis (HP:0100614) | 2.78281272 |
| 20 | Recurrent fungal infections (HP:0002841) | 2.77792582 |
| 21 | Excessive salivation (HP:0003781) | 2.74817438 |
| 22 | Nephrogenic diabetes insipidus (HP:0009806) | 2.70385885 |
| 23 | Panhypogammaglobulinemia (HP:0003139) | 2.67583653 |
| 24 | Focal motor seizures (HP:0011153) | 2.65671675 |
| 25 | Recurrent bronchitis (HP:0002837) | 2.65087676 |
| 26 | Thyroiditis (HP:0100646) | 2.64877120 |
| 27 | Chronic otitis media (HP:0000389) | 2.60988041 |
| 28 | Absent frontal sinuses (HP:0002688) | 2.58924574 |
| 29 | Lissencephaly (HP:0001339) | 2.58896146 |
| 30 | IgM deficiency (HP:0002850) | 2.57968283 |
| 31 | Nephronophthisis (HP:0000090) | 2.53342654 |
| 32 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.49622777 |
| 33 | Pancreatic fibrosis (HP:0100732) | 2.49409912 |
| 34 | T lymphocytopenia (HP:0005403) | 2.47999282 |
| 35 | Abnormality of the nasal mucosa (HP:0000433) | 2.43941080 |
| 36 | Short 4th metacarpal (HP:0010044) | 2.42750263 |
| 37 | Aplasia/Hypoplasia of the 4th metacarpal (HP:0010042) | 2.42750263 |
| 38 | Molar tooth sign on MRI (HP:0002419) | 2.41976058 |
| 39 | Abnormality of midbrain morphology (HP:0002418) | 2.41976058 |
| 40 | Acute myeloid leukemia (HP:0004808) | 2.41213971 |
| 41 | Macroorchidism (HP:0000053) | 2.40656352 |
| 42 | Hyperacusis (HP:0010780) | 2.40617780 |
| 43 | Gastrointestinal inflammation (HP:0004386) | 2.40411294 |
| 44 | True hermaphroditism (HP:0010459) | 2.40054543 |
| 45 | Eczematoid dermatitis (HP:0000976) | 2.39554488 |
| 46 | Inflammation of the large intestine (HP:0002037) | 2.38384377 |
| 47 | Chest pain (HP:0100749) | 2.37886455 |
| 48 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 2.37424729 |
| 49 | Absent speech (HP:0001344) | 2.36746648 |
| 50 | Stomatitis (HP:0010280) | 2.34849367 |
| 51 | Basal cell carcinoma (HP:0002671) | 2.34147074 |
| 52 | Limb dystonia (HP:0002451) | 2.33979063 |
| 53 | Subacute progressive viral hepatitis (HP:0006572) | 2.32941626 |
| 54 | Long eyelashes (HP:0000527) | 2.32786728 |
| 55 | Colitis (HP:0002583) | 2.30678188 |
| 56 | Heterotopia (HP:0002282) | 2.29652506 |
| 57 | Viral hepatitis (HP:0006562) | 2.28941846 |
| 58 | Recurrent cutaneous fungal infections (HP:0011370) | 2.26318725 |
| 59 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.26318725 |
| 60 | Abnormality of the corticospinal tract (HP:0002492) | 2.25940050 |
| 61 | Abnormality of T cell number (HP:0011839) | 2.24797505 |
| 62 | Pachygyria (HP:0001302) | 2.24778921 |
| 63 | Genital tract atresia (HP:0001827) | 2.24535811 |
| 64 | Oligodactyly (hands) (HP:0001180) | 2.23712478 |
| 65 | Recurrent abscess formation (HP:0002722) | 2.22885130 |
| 66 | Cellulitis (HP:0100658) | 2.22285013 |
| 67 | Chronic hepatic failure (HP:0100626) | 2.21892981 |
| 68 | Hypothermia (HP:0002045) | 2.20432367 |
| 69 | Amaurosis fugax (HP:0100576) | 2.19913024 |
| 70 | Abnormality of the renal medulla (HP:0100957) | 2.19026287 |
| 71 | Meningitis (HP:0001287) | 2.18578394 |
| 72 | Recurrent bacterial skin infections (HP:0005406) | 2.17585988 |
| 73 | Prominent nose (HP:0000448) | 2.16824963 |
| 74 | Arterial thrombosis (HP:0004420) | 2.16277191 |
| 75 | Papillary thyroid carcinoma (HP:0002895) | 2.16142401 |
| 76 | Agammaglobulinemia (HP:0004432) | 2.14811400 |
| 77 | Vaginal atresia (HP:0000148) | 2.13501007 |
| 78 | Poor coordination (HP:0002370) | 2.13166084 |
| 79 | Widely spaced teeth (HP:0000687) | 2.12133436 |
| 80 | Cortical dysplasia (HP:0002539) | 2.12130497 |
| 81 | Abnormality of T cells (HP:0002843) | 2.12106607 |
| 82 | Abolished electroretinogram (ERG) (HP:0000550) | 2.09593442 |
| 83 | Lip pit (HP:0100267) | 2.06377126 |
| 84 | Spinal cord lesions (HP:0100561) | 2.05773235 |
| 85 | Syringomyelia (HP:0003396) | 2.05773235 |
| 86 | Lymphopenia (HP:0001888) | 2.05292433 |
| 87 | Thyroid-stimulating hormone excess (HP:0002925) | 2.04746835 |
| 88 | Amyotrophic lateral sclerosis (HP:0007354) | 2.03640665 |
| 89 | Chronic obstructive pulmonary disease (HP:0006510) | 2.03613795 |
| 90 | Obstructive lung disease (HP:0006536) | 2.03613795 |
| 91 | Increased density of long bones (HP:0006392) | 2.02632207 |
| 92 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.02555849 |
| 93 | Progressive cerebellar ataxia (HP:0002073) | 2.02193978 |
| 94 | Mediastinal lymphadenopathy (HP:0100721) | 2.01993876 |
| 95 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 2.01867517 |
| 96 | Inability to walk (HP:0002540) | 2.01650888 |
| 97 | 3-Methylglutaconic aciduria (HP:0003535) | 2.00315633 |
| 98 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 1.99575914 |
| 99 | Abnormality of the labia minora (HP:0012880) | 1.98860778 |
| 100 | Cupped ear (HP:0000378) | 1.98834935 |
| 101 | Severe combined immunodeficiency (HP:0004430) | 1.97296234 |
| 102 | Medulloblastoma (HP:0002885) | 1.95147546 |
| 103 | Intestinal atresia (HP:0011100) | 1.94694508 |
| 104 | Gastrointestinal infarctions (HP:0005244) | 1.94434564 |
| 105 | Cerebellar dysplasia (HP:0007033) | 1.91780274 |
| 106 | Broad-based gait (HP:0002136) | 1.91257320 |
| 107 | Obsessive-compulsive behavior (HP:0000722) | 1.90548811 |
| 108 | Bronchitis (HP:0012387) | 1.90403378 |
| 109 | Stomach cancer (HP:0012126) | 1.89491304 |
| 110 | Thyroid carcinoma (HP:0002890) | 1.89486724 |
| 111 | Short tibia (HP:0005736) | 1.89059555 |
| 112 | Specific learning disability (HP:0001328) | 1.89032858 |
| 113 | Aplasia/Hypoplasia of the frontal sinuses (HP:0009119) | 1.88502654 |
| 114 | Genetic anticipation (HP:0003743) | 1.88366276 |
| 115 | Hypochromic anemia (HP:0001931) | 1.87211986 |
| 116 | Broad palm (HP:0001169) | 1.87071095 |
| 117 | Abnormality of the renal cortex (HP:0011035) | 1.86853105 |
| 118 | Dislocated radial head (HP:0003083) | 1.86640838 |
| 119 | Narrow forehead (HP:0000341) | 1.86100707 |
| 120 | Growth hormone deficiency (HP:0000824) | 1.85711515 |
| 121 | Cutis marmorata (HP:0000965) | 1.85669586 |
| 122 | Tented upper lip vermilion (HP:0010804) | 1.84733988 |
| 123 | Methylmalonic acidemia (HP:0002912) | 1.83550459 |
| 124 | Recurrent sinusitis (HP:0011108) | 1.82437768 |
| 125 | Agitation (HP:0000713) | 1.81894367 |
| 126 | Truncal obesity (HP:0001956) | 1.80604304 |
| 127 | Decreased central vision (HP:0007663) | 1.79837262 |
| 128 | Retrobulbar optic neuritis (HP:0100654) | 1.79283116 |
| 129 | Optic neuritis (HP:0100653) | 1.79283116 |
| 130 | Epileptic encephalopathy (HP:0200134) | 1.79237288 |
| 131 | Abnormality of T cell physiology (HP:0011840) | 1.79102755 |
| 132 | Narrow palate (HP:0000189) | 1.78762367 |
| 133 | Rectal prolapse (HP:0002035) | 1.78500301 |
| 134 | Congenital stationary night blindness (HP:0007642) | 1.77728679 |
| 135 | Abnormality of salivation (HP:0100755) | 1.77369631 |
| 136 | Hypoplasia of the thymus (HP:0000778) | 1.76909613 |
| 137 | Vasculitis (HP:0002633) | 1.76784916 |
| 138 | Hematochezia (HP:0002573) | 1.76706339 |
| 139 | Abnormality of ocular smooth pursuit (HP:0000617) | 1.76534093 |
| 140 | Tubulointerstitial nephritis (HP:0001970) | 1.76317971 |
| 141 | Elevated erythrocyte sedimentation rate (HP:0003565) | 1.76186063 |
| 142 | Impaired smooth pursuit (HP:0007772) | 1.75166851 |
| 143 | Polyphagia (HP:0002591) | 1.75064724 |
| 144 | Abnormal rod and cone electroretinograms (HP:0008323) | 1.74931660 |
| 145 | Hypoplastic iliac wings (HP:0002866) | 1.74922298 |
| 146 | Papilledema (HP:0001085) | 1.74740476 |
| 147 | Bicuspid aortic valve (HP:0001647) | 1.73940340 |
| 148 | Gaze-evoked nystagmus (HP:0000640) | 1.73272682 |
| 149 | Supernumerary spleens (HP:0009799) | 1.73265813 |
| 150 | Neoplasm of the oral cavity (HP:0100649) | 1.72455108 |
| 151 | Abnormality of eosinophils (HP:0001879) | 1.72374626 |
| 152 | Postaxial hand polydactyly (HP:0001162) | 1.72211122 |
| 153 | Abnormality of the radial head (HP:0003995) | 1.71432850 |
| 154 | Atonic seizures (HP:0010819) | 1.71376100 |
| 155 | Morphological abnormality of the pyramidal tract (HP:0002062) | 1.71211208 |
| 156 | Protruding tongue (HP:0010808) | 1.70994535 |
| 157 | Prominent nasal bridge (HP:0000426) | 1.70606408 |
| 158 | Eosinophilia (HP:0001880) | 1.70402846 |
| 159 | Inappropriate behavior (HP:0000719) | 1.70221132 |
| 160 | Focal seizures (HP:0007359) | 1.70180345 |
| 161 | Hip dysplasia (HP:0001385) | 1.69946827 |
| 162 | Recurrent skin infections (HP:0001581) | 1.69751435 |
| 163 | Transitional cell carcinoma of the bladder (HP:0006740) | 1.69664547 |
| 164 | Optic nerve coloboma (HP:0000588) | 1.68907988 |
| 165 | Lymphoma (HP:0002665) | 1.68451305 |
| 166 | Gastrointestinal stroma tumor (HP:0100723) | 1.68404659 |
| 167 | Increased nuchal translucency (HP:0010880) | 1.68365356 |
| 168 | Combined immunodeficiency (HP:0005387) | 1.68137239 |
| 169 | Poor eye contact (HP:0000817) | 1.66497941 |
| 170 | Myelodysplasia (HP:0002863) | 1.65836573 |
| 171 | Thick eyebrow (HP:0000574) | 1.65133443 |
| 172 | Hepatoblastoma (HP:0002884) | 1.64758425 |
| 173 | Hemoptysis (HP:0002105) | 1.64665802 |
| 174 | Broad foot (HP:0001769) | 1.64612424 |
| 175 | Colon cancer (HP:0003003) | 1.64282965 |
| 176 | Progressive inability to walk (HP:0002505) | 1.63286230 |
| 177 | Intellectual disability, severe (HP:0010864) | 1.63199777 |
| 178 | Tapered finger (HP:0001182) | 1.62830905 |
| 179 | 11 pairs of ribs (HP:0000878) | 1.62540119 |
| 180 | Gastrointestinal carcinoma (HP:0002672) | 1.62271701 |
| 181 | Renal cortical cysts (HP:0000803) | 1.59633252 |
| 182 | Cystic liver disease (HP:0006706) | 1.59108821 |
| 183 | Polymicrogyria (HP:0002126) | 1.57995792 |
| 184 | Dyskinesia (HP:0100660) | 1.57963755 |
| 185 | Dandy-Walker malformation (HP:0001305) | 1.57650751 |
| 186 | Optic nerve hypoplasia (HP:0000609) | 1.57115217 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP4K1 | 3.54603774 |
| 2 | EEF2K | 3.04439521 |
| 3 | MAP3K4 | 2.88985924 |
| 4 | CDK12 | 2.78440537 |
| 5 | MAPK13 | 2.52565225 |
| 6 | MAP4K2 | 2.46379552 |
| 7 | TXK | 2.41922739 |
| 8 | FRK | 2.41118599 |
| 9 | CASK | 2.30008133 |
| 10 | CAMKK2 | 2.19989932 |
| 11 | PKN2 | 2.15200384 |
| 12 | WNK3 | 2.13127009 |
| 13 | CDK19 | 2.12029746 |
| 14 | TRIM28 | 2.04206334 |
| 15 | BCR | 2.02179829 |
| 16 | MAP3K10 | 2.01479946 |
| 17 | NEK2 | 1.97751628 |
| 18 | BTK | 1.95686827 |
| 19 | CCNB1 | 1.92581514 |
| 20 | ITK | 1.91660246 |
| 21 | SIK2 | 1.91644673 |
| 22 | DYRK2 | 1.89527761 |
| 23 | PNCK | 1.89070579 |
| 24 | TEC | 1.80691164 |
| 25 | STK10 | 1.78559532 |
| 26 | BRD4 | 1.77543002 |
| 27 | NTRK2 | 1.76854816 |
| 28 | TGFBR1 | 1.75228845 |
| 29 | JAK3 | 1.74745936 |
| 30 | TGFBR2 | 1.71912182 |
| 31 | ERBB3 | 1.67689191 |
| 32 | MAP2K7 | 1.64196741 |
| 33 | HIPK2 | 1.62067678 |
| 34 | SCYL2 | 1.47742515 |
| 35 | TAOK3 | 1.47619050 |
| 36 | ZAP70 | 1.47516663 |
| 37 | CDK6 | 1.46553482 |
| 38 | CSNK1G2 | 1.45716212 |
| 39 | FGFR3 | 1.44123427 |
| 40 | STK3 | 1.43452971 |
| 41 | CDC7 | 1.42395406 |
| 42 | PINK1 | 1.40180998 |
| 43 | MAP3K6 | 1.38842579 |
| 44 | LRRK2 | 1.34542296 |
| 45 | MAP2K4 | 1.33343237 |
| 46 | LCK | 1.31430165 |
| 47 | HCK | 1.28695781 |
| 48 | MAP3K14 | 1.23170897 |
| 49 | MARK1 | 1.22920941 |
| 50 | ALK | 1.18967864 |
| 51 | SYK | 1.18256738 |
| 52 | GRK6 | 1.16587212 |
| 53 | CSF1R | 1.12734411 |
| 54 | PDGFRB | 1.10745507 |
| 55 | PASK | 1.10742929 |
| 56 | CDK9 | 1.10639253 |
| 57 | KIT | 1.09305284 |
| 58 | CHUK | 1.08897220 |
| 59 | JAK1 | 1.05528535 |
| 60 | FES | 1.05298740 |
| 61 | DYRK3 | 1.05201782 |
| 62 | ADRBK2 | 1.02827037 |
| 63 | PIM1 | 1.02172263 |
| 64 | ATR | 1.01776047 |
| 65 | SGK2 | 1.00585819 |
| 66 | TLK1 | 0.98586496 |
| 67 | TBK1 | 0.97356498 |
| 68 | TAOK1 | 0.95761490 |
| 69 | ZAK | 0.94588187 |
| 70 | NUAK1 | 0.93951863 |
| 71 | YES1 | 0.93619593 |
| 72 | PTK6 | 0.92927823 |
| 73 | IRAK4 | 0.92621888 |
| 74 | RET | 0.90223568 |
| 75 | CSNK1G3 | 0.90213766 |
| 76 | IKBKE | 0.90063603 |
| 77 | MAP2K3 | 0.89707155 |
| 78 | RIPK1 | 0.87764801 |
| 79 | PAK3 | 0.86914857 |
| 80 | KSR1 | 0.86117289 |
| 81 | TAF1 | 0.84845802 |
| 82 | CAMK1G | 0.84509629 |
| 83 | MINK1 | 0.82413839 |
| 84 | CSNK1G1 | 0.82234668 |
| 85 | SRPK1 | 0.80014290 |
| 86 | DYRK1A | 0.79912138 |
| 87 | CAMKK1 | 0.79230255 |
| 88 | SGK223 | 0.77830269 |
| 89 | SGK494 | 0.77830269 |
| 90 | FGFR1 | 0.76337892 |
| 91 | RPS6KB2 | 0.76087217 |
| 92 | STK11 | 0.74070868 |
| 93 | SIK3 | 0.73364045 |
| 94 | ATM | 0.73241037 |
| 95 | CDK3 | 0.72989159 |
| 96 | RPS6KB1 | 0.71918324 |
| 97 | MARK3 | 0.70875662 |
| 98 | IRAK1 | 0.70521318 |
| 99 | RPS6KA4 | 0.69965733 |
| 100 | FLT3 | 0.69555068 |
| 101 | CSK | 0.68670879 |
| 102 | CHEK1 | 0.67321454 |
| 103 | ACVR1B | 0.66526190 |
| 104 | NTRK3 | 0.66340713 |
| 105 | RPS6KA5 | 0.65133508 |
| 106 | RIPK4 | 0.64791668 |
| 107 | EPHA4 | 0.64186963 |
| 108 | LYN | 0.63886311 |
| 109 | JAK2 | 0.63743335 |
| 110 | CAMK1D | 0.62022439 |
| 111 | IKBKB | 0.61652865 |
| 112 | GRK1 | 0.61300586 |
| 113 | MARK2 | 0.60192697 |
| 114 | TESK1 | 0.59366791 |
| 115 | TNIK | 0.58913534 |
| 116 | MKNK2 | 0.58332985 |
| 117 | OXSR1 | 0.58192954 |
| 118 | MKNK1 | 0.57995822 |
| 119 | BCKDK | 0.57236228 |
| 120 | EPHA3 | 0.56994031 |
| 121 | CLK1 | 0.55619409 |
| 122 | TYK2 | 0.55190795 |
| 123 | DYRK1B | 0.53928918 |
| 124 | SGK3 | 0.53177490 |
| 125 | NLK | 0.52928678 |
| 126 | CSNK1D | 0.52709120 |
| 127 | CDK2 | 0.52540499 |
| 128 | PDGFRA | 0.51945956 |
| 129 | BRSK2 | 0.51653056 |
| 130 | CHEK2 | 0.51090588 |
| 131 | STK24 | 0.50854150 |
| 132 | PDK1 | 0.50523585 |
| 133 | MTOR | 0.50080532 |
| 134 | CAMK4 | 0.49652085 |
| 135 | PRKCQ | 0.49334341 |
| 136 | PRKCE | 0.47524049 |
| 137 | BMPR1B | 0.46973216 |
| 138 | VRK1 | 0.46512643 |
| 139 | RPS6KA2 | 0.46362396 |
| 140 | SGK1 | 0.46233046 |
| 141 | UHMK1 | 0.44624466 |
| 142 | ICK | 0.43374817 |
| 143 | MAPK14 | 0.42583136 |
| 144 | EIF2AK2 | 0.42572754 |
| 145 | PRKCG | 0.42560742 |
| 146 | LATS1 | 0.42140540 |
| 147 | CSNK1A1L | 0.41488200 |
| 148 | PRKCZ | 0.41457628 |
| 149 | FGFR2 | 0.41129132 |
| 150 | PLK2 | 0.38442148 |
| 151 | PRKG1 | 0.37816837 |
| 152 | CDK5 | 0.36638108 |
| 153 | PRKAA1 | 0.36047059 |
| 154 | MAP2K6 | 0.35162289 |
| 155 | PKN1 | 0.34296992 |
| 156 | CAMK2A | 0.33718215 |
| 157 | DAPK2 | 0.32595492 |
| 158 | CAMK1 | 0.31129549 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nicotine addiction_Homo sapiens_hsa05033 | 3.01736276 |
| 2 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.14213009 |
| 3 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.88882196 |
| 4 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.72102524 |
| 5 | GABAergic synapse_Homo sapiens_hsa04727 | 1.71457588 |
| 6 | Morphine addiction_Homo sapiens_hsa05032 | 1.71293345 |
| 7 | Basal transcription factors_Homo sapiens_hsa03022 | 1.68658958 |
| 8 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.68619024 |
| 9 | Leishmaniasis_Homo sapiens_hsa05140 | 1.63995971 |
| 10 | Taste transduction_Homo sapiens_hsa04742 | 1.62595151 |
| 11 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.62321685 |
| 12 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.61402973 |
| 13 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.60846812 |
| 14 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.57593860 |
| 15 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.55031894 |
| 16 | Protein export_Homo sapiens_hsa03060 | 1.51770811 |
| 17 | Measles_Homo sapiens_hsa05162 | 1.51561129 |
| 18 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.51313267 |
| 19 | Long-term depression_Homo sapiens_hsa04730 | 1.49911186 |
| 20 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.49457382 |
| 21 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 1.48223832 |
| 22 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.47848029 |
| 23 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.46220653 |
| 24 | Circadian entrainment_Homo sapiens_hsa04713 | 1.44845401 |
| 25 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.41694584 |
| 26 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.40546198 |
| 27 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.39791489 |
| 28 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.39355926 |
| 29 | Cocaine addiction_Homo sapiens_hsa05030 | 1.38712226 |
| 30 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.38509493 |
| 31 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.36780791 |
| 32 | Circadian rhythm_Homo sapiens_hsa04710 | 1.35121400 |
| 33 | Olfactory transduction_Homo sapiens_hsa04740 | 1.33382040 |
| 34 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.28843851 |
| 35 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 1.25491879 |
| 36 | mTOR signaling pathway_Homo sapiens_hsa04150 | 1.21629198 |
| 37 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 1.20850898 |
| 38 | Colorectal cancer_Homo sapiens_hsa05210 | 1.20472268 |
| 39 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.20165951 |
| 40 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.20058842 |
| 41 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.19438552 |
| 42 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.19160802 |
| 43 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.18736455 |
| 44 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.18542474 |
| 45 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.17274658 |
| 46 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.16686722 |
| 47 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.16586921 |
| 48 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.16135258 |
| 49 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.14941749 |
| 50 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.14540183 |
| 51 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.13237995 |
| 52 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.12502253 |
| 53 | Hepatitis B_Homo sapiens_hsa05161 | 1.12248115 |
| 54 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.11749282 |
| 55 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.11509059 |
| 56 | Viral carcinogenesis_Homo sapiens_hsa05203 | 1.09211050 |
| 57 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.08803891 |
| 58 | Platelet activation_Homo sapiens_hsa04611 | 1.03228918 |
| 59 | Viral myocarditis_Homo sapiens_hsa05416 | 1.02597703 |
| 60 | Asthma_Homo sapiens_hsa05310 | 1.02266162 |
| 61 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.01011812 |
| 62 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.00895714 |
| 63 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.00537240 |
| 64 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.99127190 |
| 65 | Influenza A_Homo sapiens_hsa05164 | 0.99042529 |
| 66 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.98799849 |
| 67 | Spliceosome_Homo sapiens_hsa03040 | 0.98513273 |
| 68 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.98472959 |
| 69 | HTLV-I infection_Homo sapiens_hsa05166 | 0.97786126 |
| 70 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.96969711 |
| 71 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.96760722 |
| 72 | DNA replication_Homo sapiens_hsa03030 | 0.96558676 |
| 73 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.95415387 |
| 74 | Alcoholism_Homo sapiens_hsa05034 | 0.93652383 |
| 75 | Long-term potentiation_Homo sapiens_hsa04720 | 0.92663944 |
| 76 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.92341417 |
| 77 | Cell cycle_Homo sapiens_hsa04110 | 0.91962936 |
| 78 | RNA polymerase_Homo sapiens_hsa03020 | 0.91941501 |
| 79 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.90382063 |
| 80 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.89428968 |
| 81 | Axon guidance_Homo sapiens_hsa04360 | 0.89334490 |
| 82 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.89243789 |
| 83 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.87842113 |
| 84 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.87452088 |
| 85 | Mismatch repair_Homo sapiens_hsa03430 | 0.87052578 |
| 86 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.86255815 |
| 87 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.85874766 |
| 88 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.85798244 |
| 89 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.85174865 |
| 90 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.85100149 |
| 91 | Endometrial cancer_Homo sapiens_hsa05213 | 0.84742987 |
| 92 | Legionellosis_Homo sapiens_hsa05134 | 0.82879371 |
| 93 | Shigellosis_Homo sapiens_hsa05131 | 0.82265777 |
| 94 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.81030538 |
| 95 | Parkinsons disease_Homo sapiens_hsa05012 | 0.80821707 |
| 96 | Renin secretion_Homo sapiens_hsa04924 | 0.80443150 |
| 97 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.79914375 |
| 98 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.78551292 |
| 99 | RNA degradation_Homo sapiens_hsa03018 | 0.78178892 |
| 100 | Apoptosis_Homo sapiens_hsa04210 | 0.77359964 |
| 101 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.76801325 |
| 102 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.76330484 |
| 103 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.74476516 |
| 104 | Tuberculosis_Homo sapiens_hsa05152 | 0.74052288 |
| 105 | RNA transport_Homo sapiens_hsa03013 | 0.73336634 |
| 106 | Thyroid cancer_Homo sapiens_hsa05216 | 0.72850327 |
| 107 | Glioma_Homo sapiens_hsa05214 | 0.71548141 |
| 108 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.71458847 |
| 109 | Gap junction_Homo sapiens_hsa04540 | 0.70897703 |
| 110 | Allograft rejection_Homo sapiens_hsa05330 | 0.70764117 |
| 111 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.70250274 |
| 112 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.69106486 |
| 113 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.68911763 |
| 114 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.68439349 |
| 115 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.67652007 |
| 116 | Ribosome_Homo sapiens_hsa03010 | 0.67446752 |
| 117 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.67393253 |
| 118 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.67284181 |
| 119 | Salmonella infection_Homo sapiens_hsa05132 | 0.66867721 |
| 120 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.66689216 |
| 121 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.66374241 |
| 122 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.65895638 |
| 123 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.65890967 |
| 124 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.65725390 |
| 125 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.65439007 |
| 126 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.65219627 |
| 127 | Prostate cancer_Homo sapiens_hsa05215 | 0.64955106 |
| 128 | Salivary secretion_Homo sapiens_hsa04970 | 0.64632258 |
| 129 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.62235039 |
| 130 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.61997561 |
| 131 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.61541306 |
| 132 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.61318275 |
| 133 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.61043774 |
| 134 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.60953739 |
| 135 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.60206596 |
| 136 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.59788592 |
| 137 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.58905792 |
| 138 | Pathways in cancer_Homo sapiens_hsa05200 | 0.58322531 |
| 139 | Base excision repair_Homo sapiens_hsa03410 | 0.57892756 |
| 140 | Hepatitis C_Homo sapiens_hsa05160 | 0.57400680 |
| 141 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.56921176 |
| 142 | Phototransduction_Homo sapiens_hsa04744 | 0.56180552 |
| 143 | Lysine degradation_Homo sapiens_hsa00310 | 0.55600680 |
| 144 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.54634359 |
| 145 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.53978689 |
| 146 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.53938226 |
| 147 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.53498691 |
| 148 | Insulin secretion_Homo sapiens_hsa04911 | 0.50241407 |
| 149 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.50074326 |
| 150 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.48251516 |
| 151 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.47485218 |
| 152 | Peroxisome_Homo sapiens_hsa04146 | 0.47338061 |
| 153 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.46424416 |
| 154 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.45297024 |
| 155 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.44985221 |
| 156 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.44684231 |
| 157 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.42297850 |

